VIVES Partners, managing company of VIVES Funds, has joined a [...]
Funding to advance EO2463 through Phase 1/2 and prepare for [...]
As global pharma grapples with shifting regulations, rising geopolitical tensions, [...]
Biostate AI has raised $12 million in Series A funding [...]
PhaseV has secured $50 million in Series A funding to [...]